rabbit anti p2x7 receptor c terminus (Alomone Labs)


Structured Review

Rabbit Anti P2x7 Receptor C Terminus, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti p2x7 receptor c terminus/product/Alomone Labs
Average 96 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Rod and Cone Pathway Signalling Is Altered in the P2X7 Receptor Knock Out Mouse"
Article Title: Rod and Cone Pathway Signalling Is Altered in the P2X7 Receptor Knock Out Mouse
Journal: PLoS ONE
doi: 10.1371/journal.pone.0029990

Figure Legend Snippet: Oligonucleotide Primer List.
Techniques Used:

Figure Legend Snippet: Antibody List.
Techniques Used: Binding Assay, Transduction

Figure Legend Snippet: To assess whether P2X7-R splice variants other than the full length, variant 1 are expressed in the WT and P2X7-KO mouse retina and also whether read through of variant 1 C-terminal mRNA occurs in the P2X7-KO mouse retina, PCR for (A) the central region of the P2X7-R which is common to variants 1, 2 and 3; (B) the C-terminus from within the start of the disruption in the P2X7-KO to the end of the mRNA (variant 1 only, primer pair A); and (C) the C-terminus from after the insertion deletion in the P2X7-KO mouse to the end of the receptor (variant 1 only, primer pair B) was completed. P2X7-R variant 1 C-terminal mRNA was absent (B–C) in the P2X7-KO mouse but N-terminal mRNA variants (likely variant 2 or 3) were still expressed (A). MW, molecular weight marker and the bright bar is 300 bp. (D–E) Protein analysis of P2X7-R splice variant expression was completed using Western blots of mouse retina (D) and cortex (E). An N-terminal specific P2X7-R antibody detected the protein transcript of variant 1 mRNA in WT samples 1 and 2 but not P2X7-KO samples 3 and 4 (68.41 kDa) of both retina and cortex. Protein for variant 2/3 (50.69 kDa/49.38 kDa) and 4 (17.2 kDa) was expressed in both WT and P2X7-KO retina and cortex. A monoclonal antibody against GAPDH was applied to the same blots and indicates that similar amounts of protein were loaded for WT and P2X7-KO samples.
Techniques Used: Variant Assay, Molecular Weight, Marker, Expressing, Western Blot

Figure Legend Snippet: Mice were dark adapted overnight and mixed (rod and cone) ERG responses were recorded in response to full field flashes from intensity −4.2 to 2.1 log cd.s/m 2 . (A–B) Representative mixed ERG waveforms for (A) WT and (B) P2X7-KO mice are presented. (C) There was no change in the amplitude of the rod photoreceptor derived component, a-wave, as a function of intensity. (D) The amplitude of the post-photoreceptor response, the b-wave was larger in P2X7-KO mice than in WT mice across almost all intensities tested. * indicates p<0.05, a significant difference between WT and P2X7-KO.
Techniques Used: Derivative Assay

Figure Legend Snippet: (A) Representative waveforms of the rod ERG recorded from WT (black) and P2X7-KO mice (grey) in response to a 2.1 log cd.s/m 2 intensity flash. The photoreceptor derived, rod PIII (modelled a-wave) was not altered in either (B) amplitude or (C) sensitivity in the P2X7-KO mouse when compared with the WT response. The post-photoreceptor, rod PII (modelled b-wave) was found to be (D) larger in amplitude and (E) faster to reach a maximum response. (F) The amplitude of the third of the inner retinal derived oscillatory potentials was significantly enhanced in the P2X7-KO mouse. * indicates p<0.05, a significant difference between WT and P2X7-KO.
Techniques Used: Derivative Assay

Figure Legend Snippet: (A) Representative waveforms of the cone ERG recorded from WT (black) and P2X7-KO mice (grey) in response to a 2.1 log cd.s/m 2 intensity flash. The post-photoreceptor, cone PII (modelled b-wave) was found to be larger in (B) amplitude but not faster to reach a maximum response (C) in the P2X7-KO mouse when compared with the WT response. (D) The photopic visual acuity, assessed using the optokinetic reflex to determine the spatial frequency threshold, was higher in the P2X7-KO mouse than in the WT. * indicates p<0.05, a significant difference between WT and P2X7-KO.
Techniques Used:

Figure Legend Snippet: Transverse sections of paraffin embedded retina from (A) WT and (B) P2X7-KO mice were stained with hematoxylin and eosin for comparison. The gross retinal morphology was similar in both mice. Scale bar, 20 microns.
Techniques Used: Staining

Figure Legend Snippet: (A) Immunohistochemistry on a transverse retinal section from a WT mouse showing P2X7-R immunoreactivity in the outer plexiform layer (OPL), inner nuclear layer (INL), and ganglion cell layer (GCL). (C) The retina does not label with the P2X7-R antibody following incubation with P2X7-R specific peptide. Scale bar, 20 microns.
Techniques Used: Immunohistochemistry, Incubation

Figure Legend Snippet: (A) P2X7-R IR (green) colocalises with horizontal cells labelled with Calbindin (red) and their terminals. (B) P2X7-R IR (green) colocalises with rod bipolar cells labelled with PKC (red). (C) Inset of rod bipolar cell terminals. (D) P2X7-R IR (green) puncta are discretely expressed within photoreceptor terminals labelled with PSD-95 (red). (E) Cone bipolar cells (Type 2 and 6) labelled with a ZNP-1 antibody (green) colocalise with P2X7-R IR (red) including both the cone bipolar cell dendrites and terminals (F). P2X7-R IR (green) colocalises with amacrine cells labelled with calretinin (G) and in particular GABAergic amacrine cells (H). (I) Ganglion cells labelled with an antibody against GFP in the Thy1-HYFP mouse (pseudo-coloured red) were P2X7-R IR (pseudo-coloured green). Scale bar, 10 microns.
Techniques Used:

Figure Legend Snippet: (A) P2X7-R IR (red) is associated with but does not colocalise with ribbon synapses (ribeye, green) on bipolar cell terminals (VGLUT, blue). (B) Magnified inset from A, arrows indicate ribbon synapses associated with P2X7-R IR puncta. (C) P2X7-R IR (red) colocalises with conventional synapses (bassoon, green) distinct from bipolar cell terminals (VGLUT, blue). (D) Magnified inset from C, arrows indicate conventional synapses that colocalise with P2X7-R IR puncta. Co-localisation analysis indicates that P2X7-R IR puncta do not co-localise with ribbon synapses (E) but do show significant colocalisation with conventional synapses (F) in the IPL. Scale bars are 5 microns for A & C and 2 microns for B & D.
Techniques Used:

Figure Legend Snippet: Ribbons are indicated by arrows and labelled amacine cells are indicated by astericks. (A), (B) & (C) P2X7-R immunoreactivity labels amacrine cells adjacent to rod bipolar cell ribbon synapses in the IPL. (D) A conventional amacrine cell synapse is labelled for P2X7 immunoreactivity in close proximity to a rod bipolar cell terminal. Scale bars are 200 nm for A & B and 500 nm for C & D.
Techniques Used:

Figure Legend Snippet: (A–B) Müller cells, labelled with an antibody against glutamine synthetise (red) were found to be closely associated with P2X7-R-IR puncta in the IPL (green), but not co-localised in the IPL. (C) Astrocytes, labelled with glial fibrilliary acidic protein (GFAP; red) and P2X7-R-IR (green) were found to co-localise in retinal flat mount. (D) Microglia labelled with mouse anti-GFP (pseudo-coloured red) from CX3CR1-GFP heterozygous mice were also found to co-localise with P2X7-R-IR (pseudo-coloured green). Scale bar, 10 microns.
Techniques Used:
rabbit anti p2x7 receptor c terminus (Alomone Labs)


Structured Review

Rabbit Anti P2x7 Receptor C Terminus, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti p2x7 receptor c terminus/product/Alomone Labs
Average 96 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Rod and Cone Pathway Signalling Is Altered in the P2X7 Receptor Knock Out Mouse"
Article Title: Rod and Cone Pathway Signalling Is Altered in the P2X7 Receptor Knock Out Mouse
Journal: PLoS ONE
doi: 10.1371/journal.pone.0029990

Figure Legend Snippet: Oligonucleotide Primer List.
Techniques Used:

Figure Legend Snippet: Antibody List.
Techniques Used: Binding Assay, Transduction

Figure Legend Snippet: To assess whether P2X7-R splice variants other than the full length, variant 1 are expressed in the WT and P2X7-KO mouse retina and also whether read through of variant 1 C-terminal mRNA occurs in the P2X7-KO mouse retina, PCR for (A) the central region of the P2X7-R which is common to variants 1, 2 and 3; (B) the C-terminus from within the start of the disruption in the P2X7-KO to the end of the mRNA (variant 1 only, primer pair A); and (C) the C-terminus from after the insertion deletion in the P2X7-KO mouse to the end of the receptor (variant 1 only, primer pair B) was completed. P2X7-R variant 1 C-terminal mRNA was absent (B–C) in the P2X7-KO mouse but N-terminal mRNA variants (likely variant 2 or 3) were still expressed (A). MW, molecular weight marker and the bright bar is 300 bp. (D–E) Protein analysis of P2X7-R splice variant expression was completed using Western blots of mouse retina (D) and cortex (E). An N-terminal specific P2X7-R antibody detected the protein transcript of variant 1 mRNA in WT samples 1 and 2 but not P2X7-KO samples 3 and 4 (68.41 kDa) of both retina and cortex. Protein for variant 2/3 (50.69 kDa/49.38 kDa) and 4 (17.2 kDa) was expressed in both WT and P2X7-KO retina and cortex. A monoclonal antibody against GAPDH was applied to the same blots and indicates that similar amounts of protein were loaded for WT and P2X7-KO samples.
Techniques Used: Variant Assay, Molecular Weight, Marker, Expressing, Western Blot

Figure Legend Snippet: Mice were dark adapted overnight and mixed (rod and cone) ERG responses were recorded in response to full field flashes from intensity −4.2 to 2.1 log cd.s/m 2 . (A–B) Representative mixed ERG waveforms for (A) WT and (B) P2X7-KO mice are presented. (C) There was no change in the amplitude of the rod photoreceptor derived component, a-wave, as a function of intensity. (D) The amplitude of the post-photoreceptor response, the b-wave was larger in P2X7-KO mice than in WT mice across almost all intensities tested. * indicates p<0.05, a significant difference between WT and P2X7-KO.
Techniques Used: Derivative Assay

Figure Legend Snippet: (A) Representative waveforms of the rod ERG recorded from WT (black) and P2X7-KO mice (grey) in response to a 2.1 log cd.s/m 2 intensity flash. The photoreceptor derived, rod PIII (modelled a-wave) was not altered in either (B) amplitude or (C) sensitivity in the P2X7-KO mouse when compared with the WT response. The post-photoreceptor, rod PII (modelled b-wave) was found to be (D) larger in amplitude and (E) faster to reach a maximum response. (F) The amplitude of the third of the inner retinal derived oscillatory potentials was significantly enhanced in the P2X7-KO mouse. * indicates p<0.05, a significant difference between WT and P2X7-KO.
Techniques Used: Derivative Assay

Figure Legend Snippet: (A) Representative waveforms of the cone ERG recorded from WT (black) and P2X7-KO mice (grey) in response to a 2.1 log cd.s/m 2 intensity flash. The post-photoreceptor, cone PII (modelled b-wave) was found to be larger in (B) amplitude but not faster to reach a maximum response (C) in the P2X7-KO mouse when compared with the WT response. (D) The photopic visual acuity, assessed using the optokinetic reflex to determine the spatial frequency threshold, was higher in the P2X7-KO mouse than in the WT. * indicates p<0.05, a significant difference between WT and P2X7-KO.
Techniques Used:

Figure Legend Snippet: Transverse sections of paraffin embedded retina from (A) WT and (B) P2X7-KO mice were stained with hematoxylin and eosin for comparison. The gross retinal morphology was similar in both mice. Scale bar, 20 microns.
Techniques Used: Staining

Figure Legend Snippet: (A) Immunohistochemistry on a transverse retinal section from a WT mouse showing P2X7-R immunoreactivity in the outer plexiform layer (OPL), inner nuclear layer (INL), and ganglion cell layer (GCL). (C) The retina does not label with the P2X7-R antibody following incubation with P2X7-R specific peptide. Scale bar, 20 microns.
Techniques Used: Immunohistochemistry, Incubation

Figure Legend Snippet: (A) P2X7-R IR (green) colocalises with horizontal cells labelled with Calbindin (red) and their terminals. (B) P2X7-R IR (green) colocalises with rod bipolar cells labelled with PKC (red). (C) Inset of rod bipolar cell terminals. (D) P2X7-R IR (green) puncta are discretely expressed within photoreceptor terminals labelled with PSD-95 (red). (E) Cone bipolar cells (Type 2 and 6) labelled with a ZNP-1 antibody (green) colocalise with P2X7-R IR (red) including both the cone bipolar cell dendrites and terminals (F). P2X7-R IR (green) colocalises with amacrine cells labelled with calretinin (G) and in particular GABAergic amacrine cells (H). (I) Ganglion cells labelled with an antibody against GFP in the Thy1-HYFP mouse (pseudo-coloured red) were P2X7-R IR (pseudo-coloured green). Scale bar, 10 microns.
Techniques Used:

Figure Legend Snippet: (A) P2X7-R IR (red) is associated with but does not colocalise with ribbon synapses (ribeye, green) on bipolar cell terminals (VGLUT, blue). (B) Magnified inset from A, arrows indicate ribbon synapses associated with P2X7-R IR puncta. (C) P2X7-R IR (red) colocalises with conventional synapses (bassoon, green) distinct from bipolar cell terminals (VGLUT, blue). (D) Magnified inset from C, arrows indicate conventional synapses that colocalise with P2X7-R IR puncta. Co-localisation analysis indicates that P2X7-R IR puncta do not co-localise with ribbon synapses (E) but do show significant colocalisation with conventional synapses (F) in the IPL. Scale bars are 5 microns for A & C and 2 microns for B & D.
Techniques Used:

Figure Legend Snippet: Ribbons are indicated by arrows and labelled amacine cells are indicated by astericks. (A), (B) & (C) P2X7-R immunoreactivity labels amacrine cells adjacent to rod bipolar cell ribbon synapses in the IPL. (D) A conventional amacrine cell synapse is labelled for P2X7 immunoreactivity in close proximity to a rod bipolar cell terminal. Scale bars are 200 nm for A & B and 500 nm for C & D.
Techniques Used:

Figure Legend Snippet: (A–B) Müller cells, labelled with an antibody against glutamine synthetise (red) were found to be closely associated with P2X7-R-IR puncta in the IPL (green), but not co-localised in the IPL. (C) Astrocytes, labelled with glial fibrilliary acidic protein (GFAP; red) and P2X7-R-IR (green) were found to co-localise in retinal flat mount. (D) Microglia labelled with mouse anti-GFP (pseudo-coloured red) from CX3CR1-GFP heterozygous mice were also found to co-localise with P2X7-R-IR (pseudo-coloured green). Scale bar, 10 microns.
Techniques Used:
rabbit polyclonal p2x7 c terminus antibody (Alomone Labs)


Structured Review

Rabbit Polyclonal P2x7 C Terminus Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal p2x7 c terminus antibody/product/Alomone Labs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Plasma Membrane Cholesterol as a Regulator of Human and Rodent P2X7 Receptor Activation and Sensitization"
Article Title: Plasma Membrane Cholesterol as a Regulator of Human and Rodent P2X7 Receptor Activation and Sensitization
Journal: The Journal of Biological Chemistry
doi: 10.1074/jbc.M114.574699

Figure Legend Snippet: P2X7 receptor-mediated dye uptake is enhanced by depletion of plasma membrane cholesterol and reduced by loading of cholesterol. A , example confocal images captured during 245-s time series to measure dye uptake. Time of image capture, in seconds, is shown. Ethidium bromide was added at 20 s, and 300 μ m BzATP was added at 45 s. The increase in fluorescence as a result of ethidium uptake ( red ) into P2X7-expressing cells ( green ) is apparent. B , human P2X7-mediated dye uptake was slower than mouse P2X7-mediated dye uptake ( n = 3 coverslips, ∼10–30 cells per coverslip, p < 0.001), normalized to human P2X7. C , measurements of cholesterol ( chol ) in TSA 201 cells. A 15-min preincubation with 5 or 15 m m MCD reduced cholesterol, 5 m m αCD for 15 min had no effect, and 100 μg/ml water soluble cholesterol for 30 min increased cholesterol ∼2-fold ( n = 3, *, p < 0.01, **, p < 0.001; ns , not significant). D , time course of human P2X7-mediated dye uptake, normalized to control. Uptake was enhanced by 5 m m MCD and inhibited by 100 μg/ml cholesterol ( n = 3–4, p < 0.05). E , 5 m m αCD has no effect on human P2X7-mediated dye uptake, normalized to the untreated condition ( n = 3, p > 0.05). F , rate of P2X7-mediated dye uptake 10–50 s after agonist application, normalized to control. Human P2X7 dye uptake was increased ∼5-fold by 5 m m MCD and almost abolished by 100 μg/ml cholesterol ( n = 66 alone, n = 64 MCD and n = 6 cholesterol, **, p < 0.001). Mouse P2X7 dye uptake was increased ∼2.2-fold by MCD and reduced by cholesterol ( n = 88 alone, n = 50 MCD and n = 4 cholesterol, **, p < 0.001). G , concentration-response curves for mouse P2X7 receptor-mediated dye uptake, with and without pretreatment with 5 m m MCD. Responses were normalized to the rate of increase in fluorescence in untreated cells stimulated with 300 μ m BzATP. H , time course of dye uptake mediated by the more active mouse P2X7k variant, stimulated with 30 μ m BzATP, normalized to the untreated condition ( n = 3, p < 0.05 for MCD, p < 0.001 for cholesterol). I , rat P2X7 dye uptake was enhanced by 5 m m MCD, but not significantly ( p = 0.07), and inhibited by 100 μg/ml cholesterol ( n = 3, p < 0.05), normalized to the untreated condition. J , in mouse bone marrow-derived macrophages, dye uptake via endogenous P2X7 was potentiated by 5 m m MCD and reduced by 100 μg/ml cholesterol ( n = 4, p < 0.001 for MCD, p < 0.01 for cholesterol), normalized to the untreated condition.
Techniques Used: Fluorescence, Expressing, Concentration Assay, Variant Assay, Derivative Assay

Figure Legend Snippet: The enhancement in P2X7 receptor-mediated dye uptake by MCD treatment is independent of pannexin-1 and cytoskeletal changes. A , neither carbenoxolone (+ carb ; 30 μ m ) nor pretreatment with the caspase inhibitor zVAD-FMK (+ zVAD ; 5 μ m for 1 h) reduced human P2X7-mediated ethidium uptake following MCD treatment. ( n = 6, p > 0.05). B , preincubation with (−)-blebbistatin (+ bleb ; 100 μ m for 1 h), an inhibitor of non-muscle myosin 2, had no effect on the rate of mouse P2X7-mediated dye uptake, with or without MCD pretreatment ( n = 12, p > 0.05). C , the actin-stabilizing agent jasplakinolide (+ jasp ; 30 n m for 1 h) had no effect on human P2X7-mediated dye uptake with or without MCD treatment ( n = 4–8, p > 0.05). D , latrunculin-A (+ lat ; 5 μ m for 30 min), an inhibitor of F-actin polymerization, had no effect on the initial rate of mouse P2X7-mediated dye uptake, with or without MCD treatment ( n = 3–6, p > 0.05).
Techniques Used:

Figure Legend Snippet: Acute changes in cholesterol affect P2X7 whole-cell current amplitude, sensitization and NMDG permeability. A , example traces of whole-cell patch clamp recordings from HEK 293 cells expressing the mouse P2X7 receptor and enhanced GFP, stimulated with repeated 5-s applications of 300 μ m BzATP followed by a 1-min wash. chol , cholesterol. B , mean current densities after one or more applications of BzATP, in untreated cells or cells pretreated with 5 m m αCD, 5 m m MCD, or 100 μg/ml cholesterol ( n = 3–18 cells, *, p < 0.01, **, p < 0.001; ns , not significant). pF , picofarads. C , example traces of whole-cell recordings from cells expressing the human P2X7 receptor, stimulated with repeated 5-s applications of 300 μ m BzATP followed by a 1-min wash. D , mean current density upon first agonist application, with and without 5 m m MCD pretreatment ( n = 18 cells, **, p < 0.001). E , -fold change in current density from first agonist application to last application (>10), where each point represents one cell. The solid line shows mean -fold change, and the dotted line is at 1. F–H , mouse P2X7 receptor currents in the NMDG + extracellular solution, stimulated with 300 μ m BzATP for 40 s. Mean peak current densities and the 10–90% rise time are shown ( n = 7–9, *, p < 0.01). I , TSA 201 cells expressing mouse P2X7 or human P2X7 receptors were untreated or treated with 5 m m MCD for 15 min and then surface-labeled with sulfo-NHS-LC-biotin. For mouse P2X7, 3 wells of a 6-well plate of cells were then solubilized in 350 μl of solubilization buffer, whereas for human P2X7, a T75 flask of cells was solubilized in 1 ml. The Western blot shows the total lysate ( T ) and surface-biotinylated sample ( B ) blotted for P2X7 and β-actin. MCD treatment did not affect the proportion of P2X7 receptors at the surface.
Techniques Used: Permeability, Patch Clamp, Expressing, Labeling, Western Blot

Figure Legend Snippet: The N terminus is important for the sensitivity of P2X7 receptor activity to cholesterol depletion. A , amino acid sequence alignment of the N-terminal region of human P2X1, P2X2, and P2X7 receptors, with conserved amino acids highlighted in gray , P2X1 aa20–23 and equivalent residues in P2X2 underlined , and the P2X7 residues Lys 17 and Val 18 in red. B , time course of dye uptake mediated by the K17R/V18M mutant and wild type P2X7, alone, pretreated with MCD and loaded with cholesterol ( chol ), normalized to the untreated WT P2X7. C , bar graph of the relative rate of dye uptake normalized to the untreated WT P2X7. Dye uptake mediated by the K17R/V18M mutant is not potentiated by MCD, but is inhibited by cholesterol loading (WT: n = 14 alone, n = 11 MCD, n = 3 cholesterol; mutants: n = 12 alone, n = 11 MCD, n = 3 cholesterol; *, p < 0.05, **, p < 0.001; ns , not significant). D , whole-cell patch clamp recordings of human P2X7 K17R/V18M receptor ± 5 m m MCD pretreatment, stimulated with repeated 5-s applications of 300 μ m BzATP followed by a 1-min wash. E , mean peak current density upon first application of BzATP. MCD pretreatment potentiates initial current density ( n = 10–17 cells, **, p < 0.001), but the extent of potentiation is less than the wild type receptor ( p < 0.05, two-way analysis of variance). pF , picofarads.
Techniques Used: Activity Assay, Sequencing, Mutagenesis, Relative Rate, Patch Clamp

Figure Legend Snippet: Cholesterol-sensing within the proximal C terminus of the P2X7 receptor. A , amino acid sequence of the human P2X7 N terminus and TMD1, and the end of the TMD2 and proximal C terminus. The CRAC motifs are underlined , with constituent residues in bold and central tyrosines in red. Arrows indicate the amino acids reported to interact with phosphatidylinositol 4,5-bisphosphate , and the cluster of hydrophobic residues downstream of these is in bold/blue . The 18-amino acid cysteine-rich region is highlighted in gray , and its cysteines are in bold/green. B , bar graph of the relative rates of dye uptake ± 5 m m MCD for P2X7 Tyr to Phe mutants normalized to the untreated WT P2X7 (WT: alone n = 16, MCD n = 5; mutants: n = 3–6; *, p < 0.01, **, p < 0.001; ns , not significant). C , cells expressing P2X7 WT or P2X7 mutants were surface-labeled with sulfo-NHS-LC-biotin. The Western blot shows the total lysate ( T ) and surface-biotinylated sample ( B ) blotted for P2X7 and β-actin. The Y51F mutation inhibited surface and total expression of the receptor. D , bar graph of the relative rates of dye uptake ± 5 m m MCD, for hydrophobic to alanine mutants normalized to the untreated WT P2X7 (WT: n = 9; mutants: n = 3–6; *, p < 0.05, **, p < 0.001). E , cells expressing P2X7 WT or P2X7 mutants were surface-labeled with sulfo-NHS-LC-biotin. The Western blot shows the total lysate ( T ) and surface-biotinylated sample ( B ) blotted for P2X7 and β-actin. Surface expression was inhibited by V401A, F403A, and V404A mutations.
Techniques Used: Sequencing, Expressing, Labeling, Western Blot, Mutagenesis

Figure Legend Snippet: Bromopalmitate pretreatment inhibits surface expression of the P2X7 receptor but does not abolish sensitivity to MCD. A and B , time course of dye uptake by mouse P2X7 receptor ( A ) and human P2X7 receptor ( B ) after 16 h of pretreatment with 100 μ m BrP or DMSO (control). P2X7 receptor-mediated dye uptake in BrP-treated cells was significantly potentiated by 5 m m MCD ( n = 4 for mouse, n = 3 for human, p < 0.05). C , HeLa cells expressing mouse P2X7-FLAG receptors were immunostained by live labeling with anti-FLAG antibody. BrP reduced the surface expression of mouse P2X7-FLAG, but MCD treatment did not ( scale bar = 20 μm, n = 32–40 cells per condition, **, p < 0.001; ns , not significant). D , Western blot of TSA 201 cells expressing mouse P2X7 shows that pretreatment with BrP reduces total expression of the receptor.
Techniques Used: Expressing, Labeling, Western Blot

Figure Legend Snippet: The cysteine-rich region within the proximal C terminus of P2X7 is important for normal pore dilation. A , time course of dye uptake mediated by P2X7 Δ18aa ± 5 m m MCD normalized to the untreated WT P2X7. B , relative rates of dye uptake mediated by P2X7 Δ18aa ± MCD, normalized to untreated WT P2X7 (WT: n = 6 alone, n = 2 MCD; mutants: n = 7 alone, n = 4 MCD; *, p < 0.05). C , Western blot shows that total ( T ) and surface-biotinylated ( B ) expression of P2X7 Δ18aa was similar to WT P2X7 ( panel B ). D , example whole-cell current recording for P2X7 Δ18aa stimulated with repeated 5 s applications of 300 μ m BzATP. Currents had slow activation kinetics, exhibited run down, and were flickery. E , the mean peak current density for the first agonist application appeared to be reduced by MCD treatment, although this was not significant (alone n = 13, MCD n = 8, p > 0.05). F , bar graph of the relative rates of dye uptake ± 5 m m MCD for P2X7 Cys to Ala mutants, normalized to untreated WT P2X7. (WT: alone n = 8, MCD n = 11; Cys to Ala mutants: n = 3–6; *, p < 0.05, **, p < 0.001; ns , not significant). G , Western blot shows that surface expression of C363A and C373A mutants was similar to WT, whereas C371A and C377A mutants had reduced surface expression. H , whole-cell recording of P2X7 C363A receptor currents, stimulated with repeated 5-s applications of 300 μ m BzATP. I , P2X7 C363A mean peak current density upon first application of BzATP was potentiated by 5 m m MCD pretreatment ( n = 5, *, p < 0.05).
Techniques Used: Western Blot, Expressing, Activation Assay
rabbit polyclonal p2x7 c terminus p2x7 ct (Alomone Labs)


Structured Review
Rabbit Polyclonal P2x7 C Terminus P2x7 Ct, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal p2x7 c terminus p2x7 ct/product/Alomone Labs
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99